Serum markers variation consistent with autoschizis induced by ascorbic acid-menadione in patients with prostate cancer

Medical Oncology

Volumn 20, Issue 1, 2003, Pages 45-52

  Lasalvia Prisco, Eduardo ^a,b,c,d   Cucchi, Silvia ^c,d   Vázquez, Jesús ^b,c   Lasalvia Galante, Eduardo ^b,c   Golomar, Wilson ^b,c   Gordon, William ^d  

^a UNIVERSITY OF URUGUAY   (Uruguay)

^b National Cancer Institute   (Uruguay)

^c Interdoctors   (Uruguay)

^d PharmaBlood Inc   (United States)

Author keywords

Ascorbic acid; Chemotherapy; Menadione; Prostate cancer; Tumor cell death

Indexed keywords

ASCORBIC ACID; BIOLOGICAL MARKER; HOMOCYSTEINE; MENADIONE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD LEVEL; CANCER COMBINATION CHEMOTHERAPY; CELL COUNT; CELL DEATH; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; DRUG RESPONSE; FOLLOW UP; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; TUMOR CELL;

AGED; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASCORBIC ACID; CELL DEATH; FOLLOW-UP STUDIES; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; VITAMIN K 3;

EID: 0037231124     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1385/MO:20:1:45     Document Type: Article

References (19)

1. Riordan, N.H., et al. (1995). Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent. Med. Hypotheses 44:207-213.
2. Moertel, C.G., et al. (1985). High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N. Engl. J. Med. 312(3):137-141.
3. Chlebowski, R.T., et al. (1985). Vitamin K3 inhibition of malignant murine cell growth and human tumor colony formation. Cancer Treat. Rep. 69(5):527-532.
4. Gabai, V.L., et al. (1990). Oxidative stress, disturbance of energy balance, and death of ascites tumor cells under menadione (vitamin K3) action. Biomed. Sci. 1(4):407-413.
5. Bellomo, G., et al. (1990). Cytoskeleton as a target in menadione-induced oxidative stress in cultured mammalian cells. I. Biochemical and immunocytochemical features. J. Cell Physiol. 143(1):118-128.
6. Mitchell, J.S., et al. (1965). Clinical trial of radiosensitizers, including Synkavit and oxygen inhaled at atmospheric pressure. Acta Radiol. Ther. Phys. Biol. 3(5):329-341.
7. Akman, S.A., et al. (1984). Differential pulse polarographic determination of plasma menadione. Anal. Biochem. 141:488-493.
8. Akman, S.A., et al. (1988). Phase I trial of menadiol sodium diphosphate in advanced cancer. Proc. Am. Soc. Clin. Oncol. 7:76.
9. Noto, V., et al. (1989). Effects of sodium ascorbate (vitamin C) and 2-methyl-1,4-naphthoquinone (vitamin K3) treatment on human tumor cell growth in vitro. I. Synergism of combined vitamin C and K3 action. Cancer 63(5):901-906.
10. Venugopal, J., et al. (1996). Synergistic antitumor activity of vitamins C and K3 on human urologic tumor cell lines. Life Sci. 59:1389-1400.
11. Venugopal, M., et al. (1996). Synergistic antitumor activity of vitamins C and K3 against human prostate carcinoma cell lines. Cell Biol. Int. 20:787-797.
12. Taper, H.S., et al. (1987). Non-toxic potentiation of cancer chemotherapy by combined C and K3 vitamin pre-treatment. Int. J. Cancer 40:575-579.
13. Taper, H.S., et al. (1996). Potentiation of radiotherapy by nontoxic pretreatment with combined vitamins C and K3 in mice bearing solid transplantable tumor. Anticancer Res. 16:499-504.
14. Taper, H.S., et al. (2001). In vivo reactivation of DNAses in implanted human prostate tumors following administration of a vitamin C : K3 combination. J. Histochem. Cytochem. 49:109-120.
15. Jamison, J.M., et al. (2001). Evaluation of the in vitro and in vivo antitumor activities of vitamin C and K-3 combinations against human prostate cancer. J. Nutr. 131:158S-160S.
16. Guilloteaux, J., et al. (1998). Cancer cell necrosis by autoschizis: synergism of antitumor activity on vitamin C-vitamin K3 on human bladder carcinoma T24 cells. Scanning 20:564.
17. Guilloteaux, J., et al. (2001). Ultrastructural aspects of autoschizis: a new cancer cell death induced by the synergistic action of ascorbate/menadione on human bladder carcinoma cells. Ultrastruct. Pathol. 25:183-192.
18. Nassiri, M.R., et al. (1999). Flow cytometric evaluation of two human carcinoma cell lines confirms cell autoschizis potentiated by the synergism of vitamins C and K3 tumor cell growth in vitro. J. Scan. Microsc. 21:108-109.
19. Sung, C.-F., et al. (2002). Serum total homocysteine increases with the rapid proliferation of tumor cells and decline upon cell death: a potential new tumor marker. Clin. Chim. Acta 321:55-62.